Seven thousand two hundred ninety-four total adverse reactions, 423 of which were classified as serious, and nine deaths among the 12–17-year-olds, the Vaccine Adverse Event Reporting System (VAERS) statistics released this week total. Four of the deaths (or 44%) were cardiac-related, while three were inexplicable deaths. Suicides accounted for two of the nine fatalities.

According to the most current report, a 13-year-old child (VAERS I.D. 1406840) died two days after getting a Pfizer vaccine. Three 15-year-olds (VAERS I.D. 1187918, 1382906, and 1242573), two 16-year-olds (VAERS I.D. 1225942 and 1386841), and one 17-year-old (VAERS I.D. 1199455) were among those who died.

On June 18, the VAERS system erased the record of a 15-year-old boy (VAERS I.D. 1383620) who died after getting a Pfizer vaccine. VAERS I.D. 1382096 had been duplicated.

There were 1,164 reports of anaphylaxis among children aged 12 to 17, with 99% of cases attributed to Pfizer’s vaccine, 1.2% to Moderna, and 0.2% (or two cases) to Johnson & Johnson. There were also 171 reports of myocarditis and pericarditis (heart infection), with 169 linked to Pfizer’s Chinese Communist Party (CCP) Virus vaccine. Pfizer is involved in 28 reports of blood clotting problems.

In the United States, VAERS is the principal government-funded mechanism for reporting adverse vaccination responses. As a causal connection must be verified, reports filed to VAERS are investigated further. VAERS publishes every Friday all vaccine injury records received as of a specific date, generally a week before the release date.

A total of 387,087 total adverse events were recorded to VAERS between Dec. 14, 2020, and June 18, 2021, including 6,113 deaths, an increase of 120 deaths over the previous week, according to data released on June 18. There were also 31,240 severe trauma reports this week, up 1,369 compared to the previous week.

316.1 million CCP Virus vaccine doses had been delivered in the United States as of June 18. There were 131 million shots of Moderna’s vaccine, 173 million doses of Pfizer’s vaccine, and 12 million doses of J&J’s CCP Virus vaccine.

As of June 18, 6,113 deaths had been documented, with 23% occurring within 48 hours of vaccination, 16% within 24 hours, and 38% occurring in persons who felt unwell within 48 hours of immunization.

The overall VAERS data for all age categories this week, from Dec. 14, 2020, to June 18, 2021, shows:

Heart diseases were responsible for 21% of deaths.
Males made up 51% of those who died, females made up 45%, and the remaining death notifications did not specify the deceased’s gender.
74.2 was the average age of death.

Two thousand two hundred and twenty-two pregnant women reported side effects from the CCP Virus vaccination as of June 18, with 737 of them reporting losing their baby or preterm birth.

Pfizer vaccines were blamed for 54% of the 3,764 cases of Bell’s Palsy documented, Moderna vaccine for 43%, and Johnson & Johnson vaccine for 8%.

There have been 344 cases of Guillain-Barré Syndrome, with Pfizer being responsible for 45% of cases, Moderna for 41%, and J&J for 20%.
There were 107,909 reports of anaphylaxis, with Pfizer’s vaccine accounting for 43% of cases, Moderna for 49%, and J&J for 8%.
There were 6,787 cases of blood clotting issues. Pfizer was responsible for 2,892 reports, Moderna for 2,394 reports, and J&J for 1,459 reports.

Pfizer is responsible for 835 cases of 1,342 myocarditis and pericarditis cases, whereas Moderna is accountable for 458 occurrences and J&J is involved in 45 cases.

The CDC’s Advisory Committee on Immunization Practices (ACIP) indicated there is a “likely association” of “mild” heart inflammation in young people after immunization, as The Defender reported on June 23.

1,200 incidences of cardiac inflammation in 16–24-year-olds, predominantly males. CDC advisory committee members admitted that mRNA CCP Virus vaccines should be labeled with a warning message.

Data from one of the agency’s safety monitoring systems, Vaccine Safety Datalink showed a rate of 12.6 cases per million in 12–39-year-olds in the 3 weeks following the second dose, Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, stated.

On June 24, the U.S. Food and Drug Administration would include a caution to CCP Virus vaccinations manufactured by Pfizer/BioNTech and Moderna about unusual cases of cardiac inflammation in adolescents and young adults, as reported by The Guardian on June 23.